Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors

M. Bots, I. Verbrugge, B.P. Martin, J.M. Salmon, M. Ghisi, A. Baker, K. Stanley, J. Shortt, G.J. Ossenkoppele, J. Zuber, A.R. Rappaport, P. Atadja, S.W. Lowe, R.W. Johnstone

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1341-1352
JournalBlood
Volume123
Issue number9
DOIs
Publication statusPublished - 2014

Cite this

Bots, M., Verbrugge, I., Martin, B. P., Salmon, J. M., Ghisi, M., Baker, A., ... Johnstone, R. W. (2014). Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors. Blood, 123(9), 1341-1352. https://doi.org/10.1182/blood-2013-03-488114